U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H23FN4O2
Molecular Weight 382.4313
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADB-FUBINACA

SMILES

CC(C)(C)[C@H](NC(=O)C1=NN(CC2=CC=C(F)C=C2)C3=CC=CC=C13)C(N)=O

InChI

InChIKey=ZSSGCSINPVBLQD-GOSISDBHSA-N
InChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)/t18-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H23FN4O2
Molecular Weight 382.4313
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA] is a synthetic cannabinoid, a Schedule I drug. ADB-FUBINACA acts as a high potency agonist of cannabinoid CB1 receptor. The compound considered to be a component of illicit smoking mixtures "spice".

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.36 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.
2016 Apr
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
2017 Apr 10
Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
2017 Aug
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:40:23 GMT 2023
Edited
by admin
on Sat Dec 16 10:40:23 GMT 2023
Record UNII
05235E1S2O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ADB-FUBINACA
Common Name English
1H-INDAZOLE-3-CARBOXAMIDE, N-((1S)-1-(AMINOCARBONYL)-2,2-DIMETHYLPROPYL)-1-((4-FLUOROPHENYL)METHYL)-
Systematic Name English
N-(1-(AMINOCARBONYL)-2,2-DIMETHYLPROPYL)-1-((4-FLUOROPHENYL)METHYL)-1H-INDAZOLE-3-CARBOXAMIDE, (S)-
Systematic Name English
N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDAZOLE-3-CARBOXAMIDE, (S)-
Common Name English
J3.293.458G
Code English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-ADB-FUBINACA
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
DEA NO. 7010
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
Code System Code Type Description
PUBCHEM
58124399
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
FDA UNII
05235E1S2O
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
WIKIPEDIA
ADB-FUBINACA
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
EPA CompTox
DTXSID70100998
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
CAS
1445583-51-6
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
SMS_ID
100000183998
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
CAS
1185282-00-1
Created by admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
EC50
TARGET -> AGONIST
EC50
TARGET -> AGONIST
Ki
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY